In our study, a relative fold change of 6.2 in GDNF gene expression by real-time PCR strengthens this association and the fold drop of 5.51 in ASD patients can be considered a diagnostic and therapeutic marker for cognitive deficit in ASD [14]. This evidence concerns the gene GDNF and Cognitive impairment.